These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 15619667

  • 1. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44.
    Cao JJ, Singleton PA, Majumdar S, Boudignon B, Burghardt A, Kurimoto P, Wronski TJ, Bourguignon LY, Halloran BP.
    J Bone Miner Res; 2005 Jan; 20(1):30-40. PubMed ID: 15619667
    [Abstract] [Full Text] [Related]

  • 2. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
    Koh JM, Lee YS, Byun CH, Chang EJ, Kim H, Kim YH, Kim HH, Kim GS.
    J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.
    Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H.
    Biochem Biophys Res Commun; 2000 Sep 07; 275(3):768-75. PubMed ID: 10973797
    [Abstract] [Full Text] [Related]

  • 6. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T, Utsuyama M, Hirokawa K.
    J Bone Miner Res; 2001 Aug 07; 16(8):1416-25. PubMed ID: 11499864
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
    Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA.
    J Bone Miner Res; 2001 Jun 07; 16(6):1004-14. PubMed ID: 11393777
    [Abstract] [Full Text] [Related]

  • 13. Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin.
    Evans BA, Elford C, Pexa A, Francis K, Hughes AC, Deussen A, Ham J.
    J Bone Miner Res; 2006 Feb 07; 21(2):228-36. PubMed ID: 16418778
    [Abstract] [Full Text] [Related]

  • 14. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts.
    Rifas L, Arackal S, Weitzmann MN.
    J Cell Biochem; 2003 Mar 01; 88(4):650-9. PubMed ID: 12577299
    [Abstract] [Full Text] [Related]

  • 15. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov 01; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
    Kanematsu M, Sato T, Takai H, Watanabe K, Ikeda K, Yamada Y.
    J Bone Miner Res; 2000 Jul 01; 15(7):1321-9. PubMed ID: 10893680
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.